254 related articles for article (PubMed ID: 2871486)
61. Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring.
Cosimi AB; Wortis HH; Delmonico FL; Russell PS
Surgery; 1976 Aug; 80(2):155-63. PubMed ID: 781887
[TBL] [Abstract][Full Text] [Related]
62. The long-term effect of delayed graft function on cadaveric renal transplants treated with low-dose cyclosporine.
Miwa H; Van Loenen M; Vanderwerf BA
Clin Transpl; 1989; ():275-80. PubMed ID: 2487572
[TBL] [Abstract][Full Text] [Related]
63. OKT3 prophylaxis in cadaveric kidney transplant recipients with delayed graft function.
Cohen DJ; Benvenisty AI; Cianci J; Hardy MA
Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):19-27. PubMed ID: 2510507
[TBL] [Abstract][Full Text] [Related]
64. Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression.
Sutherland DE; Fryd DS; Strand M; Ascher N; Simmons RL; Najarian JS
Transplant Proc; 1984 Jun; 16(3):629-32. PubMed ID: 6375030
[No Abstract] [Full Text] [Related]
65. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
Maddux MS; Veremis SA; Pollak R; Mozes MF
Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
[TBL] [Abstract][Full Text] [Related]
66. Comparison of kidney transplant survival between patients treated with cyclosporine and those treated with azathioprine and antithymocyte globulin.
Cho SI; Bradley JW; Monaco AP; Tilney NL
Am J Surg; 1984 Apr; 147(4):518-23. PubMed ID: 6370008
[TBL] [Abstract][Full Text] [Related]
67. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
[TBL] [Abstract][Full Text] [Related]
68. Renal function and somatic growth in pediatric cadaveric renal transplantation with cyclosporine-prednisone immunosuppression.
Ellis D; Avner ED; Rosenthal JT; Taylor RJ; Young LW; Palumbi MA; Hakala TR
Am J Dis Child; 1985 Nov; 139(11):1161-7. PubMed ID: 3904407
[TBL] [Abstract][Full Text] [Related]
69. A controlled randomized double-blind study of antilymphoblast globulin in cadaver renal transplantation.
Novick AC; Braun WE; Steinmuller D; Buszta C; Greenstreet R; Kiser W
Transplantation; 1983 Feb; 35(2):175-9. PubMed ID: 6338636
[TBL] [Abstract][Full Text] [Related]
70. Cyclosporine in renal transplantation: a single institutional experience.
Ferguson RM; Sommer BG
Am J Kidney Dis; 1985 Jun; 5(6):296-306. PubMed ID: 3925761
[TBL] [Abstract][Full Text] [Related]
71. Does cyclosporine influence the results of cadaver retransplantation?
Flechner SM; Lorber MI; Kerman RH; Van Buren CT; Wideman C; Kahan BD
Hum Immunol; 1985 Nov; 14(3):305-13. PubMed ID: 3902748
[TBL] [Abstract][Full Text] [Related]
72. Posttransplant neopterin excretion in renal allograft recipients--a reliable diagnostic aid for acute rejection and a predictive marker of long-term graft survival.
Reibnegger G; Aichberger C; Fuchs D; Hausen A; Spielberger M; Werner ER; Margreiter R; Wachtehr H
Transplantation; 1991 Jul; 52(1):58-63. PubMed ID: 1858155
[TBL] [Abstract][Full Text] [Related]
73. Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital.
Milford EL; Kirkman RL; Tilney NL; Strom TB; Carpenter CB
Am J Kidney Dis; 1985 Jun; 5(6):313-7. PubMed ID: 3925762
[TBL] [Abstract][Full Text] [Related]
74. Repeat cadaver kidney transplantation using cyclosporine A immunosuppression.
Anderson PA; Belitsky P; Bitter-Suermann H; Cohen AD; MacDonald AS
J Urol; 1987 Dec; 138(6):1376-8. PubMed ID: 3316714
[TBL] [Abstract][Full Text] [Related]
75. Effect of cyclosporine and delayed graft function on posttransplantation erythropoiesis.
Besarab A; Caro J; Jarrell B; Burke J; Francos G; Mallon E; Karsch R
Transplantation; 1985 Dec; 40(6):624-31. PubMed ID: 3907033
[TBL] [Abstract][Full Text] [Related]
76. Use of cyclosporine in pediatric renal transplant recipients.
Conley SB; Flechner SM; Rose G; Van Buren CT; Brewer E; Kahan BD
J Pediatr; 1985 Jan; 106(1):45-9. PubMed ID: 3880820
[TBL] [Abstract][Full Text] [Related]
77. Low dose ciclosporin from the early postoperative period yields potent immunosuppression after renal transplantation.
Brady HR; Kamel KS; Harding ME; Cook GT; deVeber GA; Cardella CJ
Nephron; 1990; 55(4):394-9. PubMed ID: 2202920
[TBL] [Abstract][Full Text] [Related]
78. Cyclosporine-steroid combination therapy in 84 cadaveric renal transplants.
Gordon RD; Iwatsuki S; Shaw BW; Starzl TE
Am J Kidney Dis; 1985 Jun; 5(6):307-12. PubMed ID: 3893105
[TBL] [Abstract][Full Text] [Related]
79. Experience with cyclosporine and steroids in clinical renal transplantation.
Tilney NL; Milford EL; Araujo JL; Strom TB; Carpenter CB; Kirkman RL
Ann Surg; 1984 Nov; 200(5):605-13. PubMed ID: 6385881
[TBL] [Abstract][Full Text] [Related]
80. A prospective randomized trial of FK506-based immunosuppression after renal transplantation.
Shapiro R; Jordan ML; Scantlebury VP; Vivas C; Fung JJ; McCauley J; Randhawa P; Demetris AJ; Irish W; Mitchell S
Transplantation; 1995 Feb; 59(4):485-90. PubMed ID: 7533343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
